Offer - Urjas Oil for just ₹ 1 X
Vasovin XL 6.5 Capsule is a commercial drug that is prescribed in the form of Capsule. Primarily, it is used for the treatment of Angina. Secondary and off-label uses of Vasovin XL 6.5 Capsule have also been mentioned below.
The optimal dosage of Vasovin XL 6.5 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Vasovin XL 6.5 Capsule have been listed ahead. These side effects of Vasovin XL 6.5 Capsule are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Vasovin XL 6.5 Capsule's effect is Moderate during pregnancy and Moderate for lactating mothers. It is important to know if Vasovin XL 6.5 Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Vasovin XL 6.5 Capsule related warnings section.
Vasovin XL 6.5 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Vasovin XL 6.5 Capsule in conditions like Anemia, Low Blood Pressure (Hypotension). Some other conditions that can be affected by Vasovin XL 6.5 Capsule are listed in the contraindications section below.
Drug interactions for Vasovin XL 6.5 Capsule have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Vasovin XL 6.5 Capsule is considered not safe while driving, and is not addictive.
Vasovin XL 6.5 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Vasovin XL 6.5 Capsule safe for pregnant women?
Vasovin Xl may have some side effects during pregnancy. Pregnant women should discontinue the use of Vasovin Xl, and talk to their doctor, if they notice any discomfort.
Is the use of Vasovin XL 6.5 Capsule safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Vasovin Xl. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Vasovin XL 6.5 Capsule on the Kidneys?
Vasovin Xl is not harmful for kidneys.
What is the effect of Vasovin XL 6.5 Capsule on the Liver?
Very few cases of side effects of Vasovin Xl on the liver have been reported.
What is the effect of Vasovin XL 6.5 Capsule on the Heart?
Very few cases of side effects of Vasovin Xl on the heart have been reported.
Vasovin XL 6.5 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Vasovin XL 6.5 Capsule unless your doctor advises you to do so -
Is this Vasovin XL 6.5 Capsule habit forming or addictive?
Vasovin XL 6.5 Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Vasovin XL 6.5 Capsule you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Vasovin XL 6.5 Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Vasovin XL 6.5 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Vasovin XL 6.5 Capsule
You can take Vasovin XL 6.5 Capsule with food.
Interaction between Alcohol and Vasovin XL 6.5 Capsule
Due to lack of research, there is no information about the side effects of taking Vasovin XL 6.5 Capsule with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 916-917
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 542-543
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (nitroglycerin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gonitro (nitroglycerin)